Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,211 | 78,049 | 185,253 | 68,436 | 67,602 |
| Marketable Securities | 318,787 | 371,295 | 284,493 | 258,978 | 284,367 |
| Receivables | 3,680 | 2,603 | 7,674 | 77,514 | 5,878 |
| TOTAL | $440,039 | $465,335 | $489,536 | $414,172 | $369,771 |
| Non-Current Assets | |||||
| PPE Net | 10,928 | 10,786 | 11,344 | 11,002 | 11,191 |
| Other Non-Current Assets | 75,354 | 78,469 | 81,083 | 85,670 | 88,230 |
| TOTAL | $86,282 | $89,255 | $92,427 | $96,672 | $99,421 |
| Total Assets | $526,321 | $554,590 | $581,963 | $510,844 | $469,192 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,259 | 1,292 | 1,635 | 2,527 | 3,277 |
| Accrued Expenses | 13,343 | 13,403 | 10,999 | 8,792 | 11,325 |
| TOTAL | $39,482 | $70,603 | $85,809 | $173,938 | $158,796 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13,654 | 45,919 | 60,497 | 148,463 | 132,261 |
| Other Non-Current Liabilities | 51,648 | 53,576 | 55,876 | 58,131 | 60,321 |
| TOTAL | $58,161 | $61,540 | $66,229 | $67,539 | $68,036 |
| Total Liabilities | $97,643 | $132,143 | $152,038 | $241,477 | $226,832 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,595 | 37,420 | 37,200 | 33,759 | 33,601 |
| Common Shares | 4 | 4 | 4 | 3 | 3 |
| Retained earnings | -129,344 | -130,475 | -116,443 | -171,474 | -194,970 |
| Other shareholders' equity | -43 | 972 | -329 | -246 | 195 |
| TOTAL | $428,678 | $422,447 | $429,925 | $269,367 | $242,360 |
| Total Liabilities And Equity | $526,321 | $554,590 | $581,963 | $510,844 | $469,192 |